1-20 of 22 results for subject:Diabetes
Librarians' tools
- Search time
- 0.246 seconds
- Solr query time
- 0.005 seconds
- Search query
- subject:Diabetes
- We searched for
- subject_t:Diabetes OR subject_ses:9636
Type
House
Session
Year
Department
Member
Primary member
More
Answering member
Legislative stage
Legislation
Subject
Publisher
To ask Her Majesty’s Government, further to the Written Answers by Earl Howe on 8 July 2013 (WA 9) and by the Parliamentary Under-Secretary of State for Public Health, Jane Ellison, on 10 March (HC Deb, col 97W), which are the forms of muscular dystrophy listed in Annex D of...
To ask Her Majesty’s Government, further to the Written Answers by Earl Howe on 8 July 2013 (WA 9) and by the Parliamentary Under-Secretary of State for Public Health, Jane Ellison, on 10 March (HC Deb, col 97W), which are the forms of muscular dystrophy listed in Annex D of...
The table of disorders caused by unhealthy mitochondrial DNA attached as Annex D in the consultation document ‘Mitochondrial Donation’ was derived from existing published tables, such as the 2011 report by the Expert Panel convened by The Human Fertilisation and Embryology Authority to review safety and efficacy of mitochondrial donation techniques. More detail about all the polymorphisms and mutations in human mitochondrial DNA is available at:
www.mitomap.org/MITOMAP
A search of the Department’s Ministerial correspondence database has identified 128 Departmental responses to correspondence received between January 2013 and September 2013, which mentioned muscular dystrophy as a condition that could be caused by mitochondrial DNA disease.
We have been consistently clear that the estimated number of cases of families at risk of serious mitochondrial disease, who might benefit from mitochondrial donation treatment, is relatively small.
The latest estimate from the Wellcome Centre for Mitochondrial Research at Newcastle University is that, initially, 10-20 families per year might be assisted by the mitochondrial donation techniques. These might include those with muscular dystrophy myopathies caused by faulty mitochondrial DNA. Mitochondrial donation would not have any impact on the 70,000 cases of muscular dystrophy that arise in the general population, that have no connection to mitochondrial disease.
To ask Her Majesty’s Government further to the Written Answers by Baroness Thornton on 6 April 2010 (WA 393) and by Earl Howe on 8 March 2011 (WA 389-90) and 18 June 2013 (WA 33), whether the Human Fertilisation and Embryology Authority’s Research Licence Committee concluded on 18 November 2009...
To ask Her Majesty’s Government further to the Written Answers by Baroness Thornton on 6 April 2010 (WA 393) and by Earl Howe on 8 March 2011 (WA 389-90) and 18 June 2013 (WA 33), whether the Human Fertilisation and Embryology Authority’s Research Licence Committee concluded on 18 November 2009...
The Human Fertilisation and Embryology Authority has advised that it has nothing to add to the information I gave the noble Lord in my Written Answer of 18 June 2013 (Official Report, col. WA 33).
My Lords, did the Minister have a chance to see the report from the London School of Tropical Medicine and Hygiene, published earlier this month, which suggested that if obesity levels could be reduced, there would be sufficient food for 1 billion people worldwide. The report pointed particularly to the United States of America and at western Europe. Does this not both justify the Government’s campaign to reduce obesity and illustrate the truth of Gandhi’s remark that there is sufficient in this world for people’s needs but not for their greeds?
My Lords, did the Minister have a chance to see the report from the London School of Tropical Medicine and Hygiene, published earlier this month, which suggested that if obesity levels could be reduced, there would be sufficient food for 1 billion people worldwide. The report pointed particularly to the United States of America and at western Europe. Does this not both justify the Government’s campaign to reduce obesity and illustrate the truth of Gandhi’s remark that there is sufficient in this world for people’s needs but not for their greeds?
I agree fully with the noble Lord. In this area, the message has to be that a healthy balanced diet is what we should all aspire to. As I mentioned in my initial Answer, obesity is one of the prime drivers for diabetes. If people can moderate their calorie intake to match their energy consumption, the world would be a healthier place.
To ask Her Majesty’s Government, further to the Written Answers by Baroness Thornton on 6 April 2010 (WA 393) and by Earl Howe on 8 March (WA 389), what answers were provided by the Human Fertilisation and Embryology Authority in response to an e-mail on 17 August 2004 by Dr...
To ask Her Majesty’s Government, further to the Written Answers by Baroness Thornton on 6 April 2010 (WA 393) and by Earl Howe on 8 March (WA 389), what answers were provided by the Human Fertilisation and Embryology Authority in response to an e-mail on 17 August 2004 by Dr...
To ask Her Majesty’s Government, further to the Written Answers by Earl Howe on 28 February (WA 218–19) and 8 March (WA 389), whetherinformation referred to or contained in records held by the Human Fertilisation and Embryology Authority provides a complete record of all information considered by the authority as...
To ask Her Majesty’s Government, further to the Written Answers by Earl Howe on 28 February (WA 218–19) and 8 March (WA 389), whetherinformation referred to or contained in records held by the Human Fertilisation and Embryology Authority provides a complete record of all information considered by the authority as...
To ask Her Majesty’s Government, further to the Written Answer by Baroness Thornton on 6 April 2010 (WA 393), whether the activities authorised by Human Fertilisation and Embryology Authority research licence R0152 still include the derivationof stem cell lines from embryos created by cell nuclear replacement using nuclei taken from...
To ask Her Majesty’s Government, further to the Written Answer by Baroness Thornton on 6 April 2010 (WA 393), whether the activities authorised by Human Fertilisation and Embryology Authority research licence R0152 still include the derivationof stem cell lines from embryos created by cell nuclear replacement using nuclei taken from...
To ask Her Majesty’s Government, further to the Written Answers by Earl Howe on 24 January (WA 96–7) and 7 February (WA 13–14), whether information was communicated to Human Fertilisation and Embryology Authority members between 16 June 2004 and 16 March 2005 in which the autoimmune nature of type 1...
To ask Her Majesty’s Government, further to the Written Answers by Earl Howe on 24 January (WA 96–7) and 7 February (WA 13–14), whether information was communicated to Human Fertilisation and Embryology Authority members between 16 June 2004 and 16 March 2005 in which the autoimmune nature of type 1...
To ask Her Majesty’s Government, further to the Written Answer by Lord Darzi of Denham on 1 April 2009 (WA 235), whether information was communicated to the Human Fertilisation and Embryology Authority (HFEA) between 16 June 2004 and 16 March 2005 in which the potential for transgressing the 14-day limit...
To ask Her Majesty’s Government, further to the Written Answer by Lord Darzi of Denham on 1 April 2009 (WA 235), whether information was communicated to the Human Fertilisation and Embryology Authority (HFEA) between 16 June 2004 and 16 March 2005 in which the potential for transgressing the 14-day limit...
To ask Her Majesty’s Government, further to the Written Answers by Earl Howe on 24 January (WA 96–7) and 7 February (WA 13–14), whether the Human Fertilisation and Embryology Authority has advised them of whether no information was communicated to Authority members prior to 16 March 2005 in which the...
To ask Her Majesty’s Government, further to the Written Answers by Earl Howe on 24 January (WA 96–7) and 7 February (WA 13–14), whether the Human Fertilisation and Embryology Authority has advised them of whether no information was communicated to Authority members prior to 16 March 2005 in which the...
To ask Her Majesty’s Government, further to the Written Answers by Earl Howe on 24 January (WA 96–7), whether no information was communicated to Human Fertilisation and Embryology Authority members prior to 16 March 2005 in which the autoimmune nature of type 1 diabetes was highlighted or queried in relation...
To ask Her Majesty’s Government, further to the Written Answers by Earl Howe on 24 January (WA 96–7), whether no information was communicated to Human Fertilisation and Embryology Authority members prior to 16 March 2005 in which the autoimmune nature of type 1 diabetes was highlighted or queried in relation...
To ask Her Majesty’s Government what consideration was given by the Human Fertilisation and Embryology Authority’s licence committee members or any of its peer reviewers to the experience of physicians at the University of Minnesota since 1984 in requiring immunosuppression for multiple transplants from non-diabetic identical twin donors to their...
To ask Her Majesty’s Government what consideration was given by the Human Fertilisation and Embryology Authority’s licence committee members or any of its peer reviewers to the experience of physicians at the University of Minnesota since 1984 in requiring immunosuppression for multiple transplants from non-diabetic identical twin donors to their...
To ask Her Majesty’s Government, further to the Written Answer by Earl Howe on 20 December 2010 (WA 247), why the minutes of the HumanFertilisation and Embryology Authority (HFEA) Research Licence Committee Meeting on 16 March 2005 contained no reference to the autoimmune nature of type 1 diabetes before concluding...
To ask Her Majesty’s Government, further to the Written Answer by Earl Howe on 20 December 2010 (WA 247), why the minutes of the HumanFertilisation and Embryology Authority (HFEA) Research Licence Committee Meeting on 16 March 2005 contained no reference to the autoimmune nature of type 1 diabetes before concluding...
To ask Her Majesty’s Government, further to the Written Answers by Baroness Thornton on 6 April 2010 (WA 393) and by Earl Howe on 20 December 2010 (WA 247), why cloned human embryos created using the nuclei from a patient with type 1 diabetes are still considered by the Human...
To ask Her Majesty’s Government, further to the Written Answers by Baroness Thornton on 6 April 2010 (WA 393) and by Earl Howe on 20 December 2010 (WA 247), why cloned human embryos created using the nuclei from a patient with type 1 diabetes are still considered by the Human...
To ask Her Majesty’s Government, further to the Written Answers by Lord Darzi of Denham on 20 May 2009 (WA 318) and 3 June 2009 (WA 88–89), by Baroness Thornton on 6 April 2010 (WA 393), and by Earl Howe on 19 July 2010 (WA 162) and 23 November 2010...
To ask Her Majesty’s Government, further to the Written Answers by Lord Darzi of Denham on 20 May 2009 (WA 318) and 3 June 2009 (WA 88–89), by Baroness Thornton on 6 April 2010 (WA 393), and by Earl Howe on 19 July 2010 (WA 162) and 23 November 2010...
To ask Her Majesty’s Government, further to the Written Answer by Earl Howe on 9 December 2010 (WA 76), whether the absence of the grounds for the Human Fertilisation and Embryology Authority (HFEA) Licence Committee's decision at the website indicated in the Answer, www.hfea.gov.uk, is due to the HFEA's established...
To ask Her Majesty’s Government, further to the Written Answer by Earl Howe on 9 December 2010 (WA 76), whether the absence of the grounds for the Human Fertilisation and Embryology Authority (HFEA) Licence Committee's decision at the website indicated in the Answer, www.hfea.gov.uk, is due to the HFEA's established...
To ask Her Majesty’s Government, further to the Written Answers by Earl Howe on 30 June (WA 282) and 23 November (WA 297), how the Human Fertilisation and Embryology Authority (HFEA) scrutinised the cloning of embryos using nuclei from a patient with type 1 diabetes and concluded that this could...
To ask Her Majesty’s Government, further to the Written Answers by Earl Howe on 30 June (WA 282) and 23 November (WA 297), how the Human Fertilisation and Embryology Authority (HFEA) scrutinised the cloning of embryos using nuclei from a patient with type 1 diabetes and concluded that this could...
To ask Her Majesty’s Government, further to the Written Answers by Baroness Thornton on 6 April (WA 406) and by Earl Howe on 19 July (WA 162), what is the evidence that deriving insulin-producing pancreatic cells from embryonic stem cells that are a genetic match for a patient with type...
To ask Her Majesty’s Government, further to the Written Answers by Baroness Thornton on 6 April (WA 406) and by Earl Howe on 19 July (WA 162), what is the evidence that deriving insulin-producing pancreatic cells from embryonic stem cells that are a genetic match for a patient with type...
To ask Her Majesty’s Government, further to the Written Answer by Earl Howe on 19 July (WA 162), what is the evidence to suggest that the proposed treatment is feasible; and how that relates to the Written Answer by Baroness Thornton on 6 April (WA 406) or the statement in...
To ask Her Majesty’s Government, further to the Written Answer by Earl Howe on 19 July (WA 162), what is the evidence to suggest that the proposed treatment is feasible; and how that relates to the Written Answer by Baroness Thornton on 6 April (WA 406) or the statement in...
To ask Her Majesty’s Government, further to the Written Answer by Earl Howe on 30 June (WA 281–2), how deriving stem cells from embryos created using the nuclei from a patient with type 1 diabetes could improve treatment of diabetes.
To ask Her Majesty’s Government, further to the Written Answer by Earl Howe on 30 June (WA 281–2), how deriving stem cells from embryos created using the nuclei from a patient with type 1 diabetes could improve treatment of diabetes.
To ask Her Majesty’s Government, further to the Written Answer by Baroness Thornton on 6 April (WA 393), what was the intended ultimate use of stem cell lines created by cell nuclear replacement with nuclei from a patient with type 1 diabetes as described in applications for research licence R0152...
To ask Her Majesty’s Government, further to the Written Answer by Baroness Thornton on 6 April (WA 393), what was the intended ultimate use of stem cell lines created by cell nuclear replacement with nuclei from a patient with type 1 diabetes as described in applications for research licence R0152...